17.86
price up icon8.24%   1.36
after-market After Hours: 17.80 -0.06 -0.34%
loading
Scilex Holding Company stock is traded at $17.86, with a volume of 98,313. It is up +8.24% in the last 24 hours and up +13.18% over the past month. Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
See More
Previous Close:
$16.50
Open:
$16.57
24h Volume:
98,313
Relative Volume:
0.41
Market Cap:
$124.23M
Revenue:
$46.74M
Net Income/Loss:
$-114.33M
P/E Ratio:
-13.84
EPS:
-1.29
Net Cash Flow:
$-21.04M
1W Performance:
-5.95%
1M Performance:
+13.18%
6M Performance:
+228.31%
1Y Performance:
-47.47%
1-Day Range:
Value
$16.18
$17.99
1-Week Range:
Value
$16.05
$20.02
52-Week Range:
Value
$3.60
$39.90

Scilex Holding Company Stock (SCLX) Company Profile

Name
Name
Scilex Holding Company
Name
Phone
(650) 516-4310
Name
Address
960 SAN ANTONIO ROAD, PALO ALTO
Name
Employee
31
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
SCLX's Discussions on Twitter

Compare SCLX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - General icon
SCLX
Scilex Holding Company
17.86 122.20M 46.74M -114.33M -21.04M -1.29
Drug Manufacturers - General icon
LLY
Lilly Eli Co
896.53 772.28B 59.42B 18.41B 6.44B 20.22
Drug Manufacturers - General icon
JNJ
Johnson Johnson
186.26 455.04B 92.15B 25.12B 20.46B 10.36
Drug Manufacturers - General icon
ABBV
Abbvie Inc
211.96 385.18B 59.64B 2.37B 18.24B 1.331
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
123.86 237.53B 54.45B 14.42B 17.15B 7.333
Drug Manufacturers - General icon
MRK
Merck Co Inc
82.49 214.76B 63.99B 19.05B 14.72B 7.5596

Scilex Holding Company Stock (SCLX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-27-25 Initiated D. Boral Capital Buy
Oct-16-24 Initiated Alliance Global Partners Buy
Jun-13-24 Initiated Rodman & Renshaw Buy
Oct-16-23 Initiated B. Riley Securities Buy
Oct-13-23 Initiated B. Riley Securities Buy
Oct-09-23 Initiated H.C. Wainwright Buy
View All

Scilex Holding Company Stock (SCLX) Latest News

pulisher
Nov 03, 2025

Scilex Holding Company Announces the Sponsorship of Dream - GlobeNewswire

Nov 03, 2025
pulisher
Nov 03, 2025

Datavault AI Announces Record Date of Nov. 14, 2025, for Dream Bowl Draft Meme Coin Distribution to All Eligible Scilex and Datavault AI Shareholders - The Manila Times

Nov 03, 2025
pulisher
Nov 03, 2025

Scilex Holding Company Stock Analysis and ForecastMarket Entry Points & The Future of Wealth Is Just a Click Away - earlytimes.in

Nov 03, 2025
pulisher
Nov 03, 2025

Will Scilex Holding Company Equity Warrant stock outperform tech sector in 2025Portfolio Gains Summary & High Accuracy Trade Signal Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Market reaction to Scilex Holding Company’s recent newsNew Guidance & Community Trade Idea Sharing - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Scilex Holding Company Equity Warrant stock maintain growth storyQuarterly Trade Report & Fast Moving Stock Watchlists - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How to use a screener to detect Scilex Holding Company Equity Warrant breakouts2025 Pullback Review & Free Weekly Chart Analysis and Trade Guides - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Applying chart zones and confluence areas to Scilex Holding Company Equity WarrantQuarterly Market Summary & Free Risk Controlled Daily Trade Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How Scilex Holding Company Equity Warrant stock benefits from global expansionJuly 2025 Opening Moves & Entry and Exit Point Strategies - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Real time alert setup for Scilex Holding Company performanceQuarterly Performance Summary & Smart Allocation Stock Tips - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Comparing Scilex Holding Company in custom built stock radarsJuly 2025 WrapUp & Precise Entry and Exit Recommendations - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will Scilex Holding Company stock split attract more investors2025 Trading Volume Trends & Reliable Price Action Trade Plans - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Using data models to predict Scilex Holding Company stock movementRisk Management & Daily Profit Maximizing Tips - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Scilex Holding Company trending in predictive chart modelsPortfolio Return Report & Entry and Exit Point Strategies - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Can Scilex Holding Company Equity Warrant stock resist sector downturnsMarket Sentiment Review & Safe Capital Allocation Plans - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Scilex Holding Company (NASDAQ:SCLX) Sees Significant Decrease in Short Interest - MarketBeat

Nov 01, 2025
pulisher
Oct 31, 2025

Scilex Holding ends equity line agreement with Tumim Stone Capital By Investing.com - Investing.com Canada

Oct 31, 2025
pulisher
Oct 31, 2025

Scilex Ends Stock Purchase Agreement with Tumim - TipRanks

Oct 31, 2025
pulisher
Oct 31, 2025

Scilex Holding ends equity line agreement with Tumim Stone Capital - Investing.com

Oct 31, 2025
pulisher
Oct 31, 2025

Momentum divergence signals in Scilex Holding Company chartChart Signals & AI Enhanced Market Trend Forecasts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How to integrate Scilex Holding Company Equity Warrant into portfolio analysis toolsJuly 2025 Review & Target Return Focused Picks - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

What technical models suggest about Scilex Holding Company Equity Warrant’s comebackJuly 2025 EndofMonth & AI Powered Trade Plan Recommendations - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Order flow analysis tools used on Scilex Holding CompanyEarnings Recap Report & Weekly Top Gainers Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Technical signs of recovery in Scilex Holding CompanyJuly 2025 Short Interest & Weekly Chart Analysis and Guides - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Using portfolio simulators with Scilex Holding Company Equity Warrant includedOptions Play & Weekly Return Optimization Plans - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

What drives Scilex Holding Company stock priceContrarian Investment Ideas & Predict Volatility With Our Neural Network - earlytimes.in

Oct 30, 2025
pulisher
Oct 30, 2025

Is Scilex Holding Company stock in correction or buying zoneWeekly Investment Report & AI Optimized Trade Strategies - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Will Scilex Holding Company stock remain a Wall Street favoriteMarket Sentiment Summary & Technical Entry and Exit Tips - newser.com

Oct 30, 2025

Scilex Holding Company Stock (SCLX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
drug_manufacturers_general SNY
$50.05
price down icon 1.05%
drug_manufacturers_general PFE
$24.66
price up icon 0.04%
$122.05
price up icon 1.89%
$296.30
price down icon 0.71%
drug_manufacturers_general NVO
$49.11
price down icon 0.71%
drug_manufacturers_general MRK
$82.49
price down icon 4.06%
Cap:     |  Volume (24h):